Dividend stocks: Marico, DB Corp, Sonata Software, 6 others to trade ex-dividend today

Dividend stocks 2023: Shares of DB Corp Ltd, Marico Ltd, Oriental Carbon & Chemicals Ltd, Siyaram Silk Mills Ltd, Sonata Software Ltd, Supreme Industries Ltd, Transport Corporation of India Ltd, Vaibhav Global Ltd, and Venus Pipes & Tubes Ltd will be in focus when the stock market opens today.

The board of directors of these companies have declared dividends for their eligible shareholders.

DB Corp Ltd has declared an interim dividend of Rs 2 per share, the Marico Ltd board has declared a Rs 3 per share interim dividend, Oriental Carbon & Chemicals Ltd has declared an Rs 7 per share interim dividend, Siyaram Silk Mills Ltd has announced Rs 4 per share interim dividend, Sonata Software Ltd has declared an interim dividend of 7 per share, Supreme Industries Ltd has declared an interim dividend of 8 per share, Transport Corporation of India Ltd has declared an interim dividend of 2.5 per share, Vaibhav Global Ltd has declared an interim dividend of 1.5 per share, and Venus Pipes & Tubes Ltd has declared Rs 0.50 per share interim dividend.

Marico— The FMCG major reported a 17.26% increase in consolidated net profit at 360 crore for the September quarter of 2023-24, driven by softer input costs. Its revenue from operations is marginally reduced to 2,476 crore during the quarter from 2,496 crore a year ago.

DB Corp – It reported net sales at 586.04 crore in the September quarter of fiscal year 2024, up 8.85% from 538.40 crore a year ago. Its quarterly net profit stood at 100.26 crore, up 105.53% from 48.78 crore a year ago. Ebitda stood at 167.57 crore in Q2 FY24, up 71.41% from 97.76 crore a year ago.

Sonata Software— The IT services and technology company reported 28% YoY growth in consolidated revenue at 1,912.6 crore for the second quarter ended 30 September 2023. Its EBITDA stood at 220.5 crore, up 33% YoY. Its PAT (profit after tax) stood at 124.2 crore, a growth of 10% YoY.

Supreme Industries–Supreme Industries Ltd posted around a three-fold jump in its profit after tax at 243.19 crore in the quarter ended September 2023, pushed by higher income. Its total income rose to 2,321.38 crore from 2,092.12 in the year-ago quarter.

Transport Corporation Of India— TCI reported a 20.3% rise in consolidated net profit to 87 crore for the quarter ended September 30, 2023. Its consolidated total income in the July-September period increased to 1,004.8 crore over 939.5 crore a year ago.

Oriental Carbon & Chemicals— The company reported a net profit of 8.96 crore in the September quarter of FY 2024, down 4.91% from 9.43 crore a year ago. Its net sales stood at 111.43 crore in the September quarter, down 20.92% from 140.91 crore last fiscal year. Ebitda stood at 24.12 crore in Q2 FY24, down 3.33% from 24.95 crore a year ago.

Siyaram Silk Mills— The company reported a net profit of 61.29 crore in the September quarter of FY 2024, down 23.51% from 80.13 crore a year ago. Its net sales stood at 585.91 crore in the September quarter, down 7.84% from 635.76 crore last fiscal year. Ebitda stood at 99.75 crore in Q2 FY24, down 22.51% from 128.72 crore a year ago.

Vaibhav Global– The company reported a net profit of 29.37 crore in the September quarter of FY 2024, up 28.08% from 22.93 crore a year ago. Its net sales stood at 705.00 crore in the September quarter, up 9.09% from Rs. 646.26 crore last fiscal year. Ebitda stood at 66.91 crore in Q2 FY24, up 28.52% from 52.06 crore a year ago.

Venus Pipes & Tubes— The company reported a 94% jump in its profit after tax (PAT) at 20.2 crore for the second quarter of this fiscal year, compared with 10 crore in the year-ago quarter. Its total sales in the second quarter of this fiscal jumped 51.3% to 191.3 crore, compared to 126.4 crore in the same period last year.

Disclaimer: The views and recommendations made above are those of individual analysts or brokering companies, and not of Mint. We advise investors to check with certified experts before taking any investment decision.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it’s all here, just a click away! Login Now!

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

More Less

Published: 07 Nov 2023, 06:40 AM IST

Turquoise Health Raises $30M for its Price Transparency Software

price transparency

Hospitals’ compliance with price transparency laws has increased In the past year, with most hospitals currently displaying the cost data they need to in order to comply significantly with the regulations. That wasn’t always the case, though. Hospitals had a difficult time meeting CMS’ price transparency requirements during the first two years they were enforced — a JAMA study published a year and a half after the rule went into effect showed that fewer than 6% of US hospitals were fully compliant.

To achieve compliance, many health systems have turned to technology vendors for assistance. One of these vendors — Turquoise Healtha San Diego-based startup selling software to reduce the complexity of healthcare pricing data — announced a new funding round on Tuesday.

The startup, which was founded in 2020, completed a $30 million Series B round, which brings its total funding to date to $55 million. The financing round was led by Adams Street Partnerswith participation from Andreessen Horowitz, BoxGroup and Yosemite. Adams Street Partner Tom Bremner will join Turquoise’s board of directors.

“Healthcare pricing remains frustratingly opaque for many industry stakeholders, including pattention,” Bremner said in a statement. “Turquoise tackles this problem head-on with a sophisticated, multi-stakeholder platform that ultimately makes healthcare pricing and packaging look easy. I am excited to partner with the team as they scale towards a seamless healthcare transaction.”

CMS began enforcing it price transparency rules on the first day of 2021. The law requires hospitals to post their gross charges, payer-specific negotiated charges, de-identified minimum negotiated charges, de-identified maximum negotiated charges and cash prices on their websites in a machine-readable file. It also mandates that hospitals must publish pricing for the 300 most commonly used services to their website in a consumer-friendly manner.

In July 2022, CMS began requiring payers to post price transparency data as well. Payers are required to post rate data for more than the services they cover at hospitals — they must publish data for all types of providers, such as imaging centers, family practice clinics, and ambulatory surgery centers.

Both hospitals and payers are required to post massive amounts of data in a consumer-friendly manner, which isn’t an easy task given the highly complex and variable nature of healthcare financial data, Turquoise CEO Chris Severn pointed out.

The complicated structure of the healthcare system — from care variance to deductibles to billing codes — means that producing an accurate price estimate is incredibly challenging. For example, there is no single price for a colonoscopy or hysterectomy. In order to figure out how much a procedure will actually cost a patient, a number of variables need to be considered, such as the facility fee, doctor’s procedure fee and anesthesia fee.

That’s why Turquoise built software to quickly gather that information and determine what a patient’s health plan will pay for. The startup’s platform provides direct access to price transparency data via a search engine, as well as tools for data viewing and reporting. Overall, this platform makes it easier to quickly provide patients with an accurate price quote, Severn explained.

Turquoise has more than 160 customers, including providers, payers, employers, consultants, health tech companies, pharmaceutical firms and medical device makers. These customers contribute to the startup’s revenue via three streams, which Severn categorized as “data, contracts and compliance.”

The data revenue stream refers to customers who buy access to negotiated rates and cash prices from providers and payers across the country. The contracts stream encompasses those that use Turquoise’s contract intelligence platform, which leverages AI to enable contract organization and insights. As for the compliance stream, this involves customers that use Turquoise’s compliance tools designed for CMS’ price transparency laws and the No Surprises Act.

There are other companies out there that also help healthcare organizations understand costs and negotiate accordingly, like Accenture, Deloitte and Healthcare Bluebook. Severn declined to answer MedCity News‘ question asking how Turquoise differentiates itself from competitors such as these.

Photo: cinemaslow, Getty Images

Research Office announces webinar for Python software users | E-News

“Python Development with Visual Studio Code,” designed to equip participants with the fundamentals of Python programming within the VSCode IDE, will be held from 3-4 pm Wednesday, Feb. 28, on Zoom.

Python is one of the most popular computer programming languages ​​for data analysis, task automation and machine learning. Because it’s relatively easy to learn, many non-programmers, such as accountants and scientists, use Python for a variety of everyday tasks.

The webinar will review how to set up the Python environment, VSCode’s powerful editing, running and debugging features, and integrating with Git for version control. Participants will also learn about useful extensions to enhance their development workflow.

The session includes a practical demonstration of building a simple Python project, offering hands-on experience with the tools and features discussed. The webinar aims to provide a solid foundation for developing Python applications efficiently using VSCode, catering to both advanced beginners and intermediate users.

Register to attend.